CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration

OBJECTIVE: Yo antibodies are associated with paraneoplastic cerebellar degeneration (PCD). We have characterized Yo sera by measuring CDR2 and CDR2L antibodies and the localization of their antigens. METHODS: Forty-two Yo sera from patients with paraneoplastic neurological syndromes (PNS), 179 sera...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichler, Tilo W., Totland, Cecilie, Haugen, Mette, Qvale, Tor H., Mazengia, Kibret, Storstein, Anette, Haukanes, Bjørn I., Vedeler, Christian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688866/
https://www.ncbi.nlm.nih.gov/pubmed/23823982
http://dx.doi.org/10.1371/journal.pone.0066002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688866/
https://www.ncbi.nlm.nih.gov/pubmed/23823982
http://dx.doi.org/10.1371/journal.pone.0066002

Ejemplares similares